Street youth are vulnerable young people whose sexual and drug-use behaviours place them at risk of contracting and transmitting sexually transmitted infections (STIs) and blood-borne infections (BBIs).1,2 One such behaviour is injection drug use (IDU). Estimates of the proportion of street youth who have ever injected drugs range from 18 to 57%2,3-7. Previously identified factors associated with IDU in street youth include histories of forced institutionalization; parental introduction to drugs or parental abandonment; lack of stable housing; integration into the street economy; and recent use of heroin, hallucinogens, cocaine, and crack.3,4,5,8
The purpose of this update is to profile IDU in Canadian street youth and highlight the differences between street youth who inject drugs and those who use drugs by non-injection routes. Information presented in this update is from the 1999, 2001, and 2003 cycles of Enhanced Surveillance of Canadian Street Youth (E-SYS), a multi-centre sentinel surveillance system that monitors rates of STIs and BBIs, risk behaviours, and health determinants in the Canadian street youth population. There were 4728 street youth recruited over this time period (1645, 1427 and 1656 in 1999, 2001 and 2003 respectively) from Vancouver, Edmonton, Saskatoon, Winnipeg, Toronto, Ottawa and Halifax; results are generalizable to street youth from these urban centres.
Figure 1: Proportion of street youth in E-SYS with a history of ever injecting drugs

Figure 2: Most commonly injected drugs in previous 3 months among street youth who injected drugs in 2001 and 2003

Note: Youth were allowed to report injecting more than one drug;
percentages therefore may exceed 100%.
|
“E-SYS is a collaboration between the Public Health Agency of Canada’s Surveillance and Epidemiology Unit (Community Acquired Infections Division, Centre for Infectious Disease Prevention and Control), Health Canada’s Office of Research and Surveillance (Drug Strategy and Controlled Substances Program), participating surveillance sites and the youth who provide the data and samples collected.” |
|
Characteristic |
IDU, % |
No IDU, % |
|
Gender |
66 |
62 |
|
Age, y |
40 |
62 |
|
Education |
52 |
38 |
|
Parent/caregiver characteristics* |
23 |
14 |
|
Youth ever lived on the streets all the time |
80 |
62 |
|
Criminal behaviour |
84 |
56 |
|
Sexual history |
IDU |
No IDU |
|
Number of lifetime sexual partners, mean |
73.4 |
19.5 |
|
Did not use a barrier during most recent sexual encounter(s), % |
59 |
49 |
|
Ever had an STI, % |
38 |
23 |
|
Ever had obligatory sex, % |
32 |
14 |
|
Ever traded sex, % |
37 |
15 |
Percentages are significantly different at p<0.05.
Figure 3: Rates of hepatitis C infection among street youth who reported IDU in E-SYS, 1999–2003

Data from E-SYS indicate that about 20% of street youth have ever injected drugs. The finding that older youth were more likely to be injection drug users is probably due to their prolonged involvement on the street. Street-involved youth who are injection drug users have a greater risk of contracting STIs and other BBIs such as hepatitis C compared to non-injectors, due to the sharing of needles and other risk behaviours.9,10
It is often difficult to develop interventions aimed at street youth who abuse substances because of the shifting or unstable environments in which they live, the lack of social infrastructure with which to implement prevention programming, and their lower school attendance compared to youth in the general population. Providing the basic necessities of life, including affordable housing or shelter, may help street youth to address their drug use and addictions.
Increased access to counselling and testing, improved access to sterile injection equipment, and the promotion of diverse treatment options may be effective in reducing the negative consequences of IDU in street youth.
Ultimately, targeting troubled youth before drug use and addictions begin by initiating comprehensive multi-sectorial (child welfare, health, educational, judicial) programs may be the key to effectively dealing with substance abuse issues.
[Hepatitis C and STI Surveillance & Epi]
. September 2000; report
to Health Canada. Accessed March 6, 2007.For further information, please contact:
Public Health Agency of Canada (PHAC)
Surveillance and Epidemiology Section
Community Acquired Infections Division (CAID)
Centre for Infectious Disease Prevention and Control (CIDPC)
AL 0603B
Ottawa, ON K1A 0K9
Tel: (613) 946-8637
Fax: (613) 946-3902
To share this page just click on the social network icon of your choice.